MALIGNANT MESOTHELIOMA
Clinical trials for MALIGNANT MESOTHELIOMA explained in plain language.
Never miss a new study
Get alerted when new MALIGNANT MESOTHELIOMA trials appear
Sign up with your email to follow new studies for MALIGNANT MESOTHELIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for Tough-to-Treat mesothelioma: targeted therapy trial
Disease control Recruiting nowThis study is testing whether the drug brentuximab vedotin can help control advanced mesothelioma that has a specific marker called CD30 and cannot be removed by surgery. The drug is designed to target and interfere with cancer cells that have CD30. About 55 patients who have had…
Matched conditions: MALIGNANT MESOTHELIOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
New hope for tough cancers: first test of experimental drug begins
Disease control Recruiting nowThis is the first time a new drug called ISM6331 is being tested in people. The main goal is to find a safe dose and understand its side effects in 100 adults with advanced cancers like mesothelioma or other solid tumors that have not responded to standard treatments. Researchers…
Matched conditions: MALIGNANT MESOTHELIOMA
Phase: PHASE1 • Sponsor: InSilico Medicine Hong Kong Limited • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Doctors reprogram Patients' own cells to attack advanced lung cancer
Disease control Recruiting nowThis early-stage study is testing the safety of a new personalized immunotherapy for people with advanced cancer that has spread to the lining of the lungs (pleura). Doctors take immune cells from a patient's own lung fluid, grow large numbers of them in a lab, and then infuse th…
Matched conditions: MALIGNANT MESOTHELIOMA
Phase: PHASE1 • Sponsor: David Bartlett, MD • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC